Newsletters 2021

Archived Newsletters from 2021

HMT Joins Global Effort to develop Covid-19 Vaccine

HMT is pleased to announce that it has signed a collaborative project agreement with AnGes, Inc. and AnGesand Osaka University for the development of a DNA vaccine against COVID-19

HMT Works from Home

During the Covid-19 crisis, we want all of our customers to know that we are still working hard from our various home offices over 5 countries worldwide, and trying to have some fun in the process!


Newsletters 2020

Archived Newsletters from 2020

Take our Metabolite Personality Quiz

Discover the metabolite most related to your personality!

HMT Young Leaders in Metabolomics Grant Awards

HMT is pleased to announce the winners of the HMT Young Leaders in Metabolomics Grant awards. We received many great proposals and look forward to working with our recipients.

Top Award

Name & Affiliation: Dr. Yorihiro Iwasaki, Tazuke Kofukai Medical Research Institute, Kitano Hospital

Research title: Elucidation of molecular basis of hyperglycemic toxicity by metabolome analysis of monocytes in diabetic patients

 

Incentive Award

Name & Affiliation: Dr. Vrushali Agashe, National Eye Institute, National Institute of Health

Research title: Extracellular vesicles as potential biomarkers in human uveitis

 

Incentive Award

Name & Affiliation: Dr. Mei Horikawa, Graduate School of Medicine, Hokkaido University

Research title: Identification of substances involved in cellular interactions via metabolites under metabolic imbalance

Why Metabolites Matter

Check out our white paper on why metabolomics is one of the fastest growing omics

HMT Newsletter- Thanksgiving Issue 2019

Learn the importance of Tryptophan

HMT announces collaboration with J-VPD, Inc.

The scope of this collaboration agreement is to offer laboratory testing services for research and clinical purposes utilizing biomarkers for mental disorders and lifestyle related diseases. At present, we will focus on the Indian market, which is sustaining a high economic growth, and striving for commercialization.

HMT starts new collaboration with UCSF

HMT has announced it's joint collaboration with UCSF to test HMT's biomarker for Major Depressive Disorder (MDD) and identify new biomarkers for mental illness

Back to Top